CART

(0) items

HIV Essentials 2011,9781449613396

HIV Essentials 2011

by ; ;
Edition:
4th
ISBN13:

9781449613396

ISBN10:
144961339X
Format:
Paperback
Pub. Date:
12/8/2010
Publisher(s):
Jones & Bartlett Learning
List Price: $24.95
More New and Used
from Private Sellers
Starting at $0.99

Rent Book

We're Sorry
Sold Out

Used Book

We're Sorry
Sold Out

eBook

We're Sorry
Not Available

New Book

We're Sorry
Sold Out


Customer Reviews

Invaluable Book   April 20, 2011
by


HIV Essentials, 2011 incorporates the latest clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management and prevention of HIV infection and its complications. Now, all of his years of experience and "research" can be found in one compelling and informative volume. Sax, Paul's writing style is both entertaining and captivating. I recommend this cheap, worthy and invaluable textbook for anyone dealing with HIV; whether personally or through a loved one.






HIV Essentials 2011: 5 out of 5 stars based on 1 user reviews.

Summary

The World's leading experts provide all the 'Essentials' needed to manage patients in the office, on the ward and in the ICU. HIV Essentials 2011 incorporates the latest clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management and prevention of HIV infection and its complications.

Topics include:

-HIV diagnosis, evaluation, treatment and prevention

-Opportunistic infections and other HIV Complications

-Treatment of HIV and pregnancy

-Antiretroviral drug summaries

-Post-exposure Prophylaxis

-New section to each drug summary called "How Supplied" describes the commercially available dosage forms for all the ARV's

''Clinicians are constantly faced with changes in this field. This update maintains its friendly format and layout, it is well written, and the information is easy to access and understand. The authors are national experts who also provide invaluable opinion based on their experience. Ideally, readers should use the outlined key references to the literature to expand on certain topics and obtain more detailed information. This book proves its usefulness once again as a pocket reference for providers and busy clinicians managing patients with HIV infection.'' -Uriel Sandkovsky, MD,University of Nebraska Medical Center

Table of Contents

Overview of HIV Infectionp. 1
Overviewp. 2
Stages of HIV Infectionp. 3
Acute HIV Infectionp. 4
Differential Diagnosisp. 4
Signs and Symptomsp. 4
Laboratory Findingsp. 4
Diagnostic Testingp. 5
Managementp. 5
Diagnosis and Evaluation of HIV Infectionp. 6
HIV Antibody Testingp. 7
ELISAp. 7
Western Blotp. 7
Othersp. 7
HIV Viral Load Assaysp. 9
Usesp. 9
Assays and Interpretationp. 9
Indicationsp. 11
Initial Assessment of HIV-Infected Patientsp. 11
Clinical Evaluationp. 11
Laboratory Testingp. 12
CD4 Cell Countp. 14
Treatment of HIV Infectionp. 15
Initiation of Antiretroviral Therapyp. 16
Selection of an Optimal Initial Antiretroviral Regimenp. 22
Complications of HIV Therapyp. 31
Lipodystrophy Syndromep. 31
Antiretroviral Therapy Adverse Effectsp. 35
Bleeding Eventsp. 36
Bone Marrow Suppressionp. 36
Cardiovascularp. 38
Central Nervous Systemp. 39
Gastrointestinal Intolerancep. 40
Hepatic Failurep. 41
Hepatoxicityp. 43
Hyperlipidemiap. 45
Hypersensitivity Reactionp. 47
Insulin Resistance/Diabetes Mellitusp. 49
Lactic Acidosis/Hepatic Steatosisp. 50
Lipodystrophyp. 53
Nephrolithiasis/Urolithiasis/Crystalluriap. 54
Nephrotoxicityp. 55
Neuromuscular Weakness Syndromep. 57
Osteonecrosisp. 58
Osteopeniap. 59
Pancreatitisp. 60
Peripheral Neuropathyp. 60
Stevens-Johnson Syndromep. 61
References and Suggested Readingsp. 64
Treatment Failure and Resistance Testingp. 66
Antiretroviral Treatment Failurep. 67
Virologic Failurep. 67
Immunologic Failurep. 68
Clinical Failurep. 68
Usual Sequence of Treatment Failurep. 68
Principles of Resistance Testingp. 72
Types of Resistance Testingp. 73
Genotype Testingp. 74
Phenotype Testingp. 74
Other Options for Resistance Testingp. 75
Co-Receptor Tropism Assayp. 75
Indications for and Approach to Resistance Testingp. 75
Important Genotype-Resistant Patternsp. 77
Nucleoside Reverse Transcriptase Inhibitors (NRTI's)p. 77
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI's)p. 77
Protease Inhibitors (Pi's)p. 79
Prophylaxis and Treatment of Opportunistic Infectionsp. 82
Prophylaxis of Opportunistic Infectionsp. 83
Treatment of Opportunistic Infectionsp. 90
Aspergillosis, Invasivep. 91
Bacterial Respiratory Diseasesp. 92
Bartonella Infectionsp. 94
Campylobacteriosisp. 95
Candidiasis (Mucosal)p. 95
Chagas Diseasep. 98
Clostridium difficile Diarrhea/Colitisp. 98
Coccidioidomycosisp. 99
Cryptococcal Meningitisp. 100
Cryptosporidiosisp. 102
Cytomegalovirus (CMV) Diseasep. 103
Hepatitis B Virus (HBV)p. 106
Hepatitis C Virus (HCV)p. 108
Herpes Simplex Virus (HSV) Diseasep. 113
HHV-6 Infectionp. 114
HHV-8 Infectionp. 115
Histoplasma capsulatump. 115
Human Papillomavirus (HPV) Diseasep. 117
Isospora belli Infectionp. 118
Leishmaniasis, Cutaneousp. 119
Leishmaniasis, Visceralp. 119
Malariap. 120
Malaria, Severep. 120
Malaria, Uncomplicatedp. 121
Microsporidiosisp. 121
Mycobaterium avium Complex (MAC) diseasep. 123
Mycobaterium tuberculosisp. 124
Penicilliosisp. 126
Pneumocystis Pneumonia (PCP)p. 127
Progressive Multifocal Leukoencephalopathy (PML)p. 129
Salmonellosisp. 130
Shigellosisp. 131
Toxoplasma gondii Encephalitisp. 132
Treponema pallidum (Syphilis)p. 133
Varicella-Zoster Virus (VZV) Diseasep. 136
Complications of HIV Infectionp. 138
Hematologic Complicationsp. 139
Thrombocytopeniap. 139
Anemiap. 139
Neutropeniap. 140
Eosinophiliap. 141
Oncologic Complicationsp. 141
Kaposi's Sarcomap. 141
Non-Hodgkin's Lymphomap. 142
Primary CNS Lymphomap. 142
Cervical Cancerp. 143
Anal Cancerp. 143
Endocrine Complicationsp. 143
Adrenal Insufficiencyp. 143
Hypogonadismp. 144
Thyroid Diseasep. 144
Pancreatitisp. 145
Hyperglycemiap. 145
Hypoglycemiap. 145
Ovarian Complicationsp. 146
Bone Diseasep. 146
Gastrointestinal Complicationsp. 147
Anorexiap. 147
Nausea/Vomitingp. 147
Diarrheap. 148
Oral or Esophageal Ulcersp. 148
HIV Cholangiopathyp. 149
Renal Complicationsp. 149
HIV-Associated Nephropathyp. 149
Medication-Related Renal Diseasep. 150
HCV-Associated Renal Diseasep. 151
Heroin Nephropathyp. 151
Cardiac Complicationsp. 151
HIV-Related Cardiomyopathyp. 151
Pericarditis/Pericardial Effusionp. 152
Tricuspid Valve Endocarditisp. 152
Pulmonary Complicationsp. 153
Pulmonary Hypertensionp. 153
Lymphocytic Interstitial Pneumonitisp. 153
Emphysemap. 153
Pulmonary Kaposi's Sarcomap. 154
HEENT Complicationsp. 154
Aphthous Ulcersp. 154
Oral Hairy Leukoplakiap. 154
Salivary Gland Enlargementp. 154
Lymphoepithelial Cystsp. 154
Gingivitis/Periodontitisp. 155
Musculoskeletal Complicationsp. 155
HIV Arthropathyp. 155
Reiter's Syndromep. 155
Pyomyositisp. 155
HIV/NRTI-Related Myopathyp. 156
Rhabdomyolysisp. 156
Neurologic Complicationsp. 156
Distal Sensory Neuropathyp. 156
Other Forms of Neuropathyp. 157
HIV-Associated/AIDS Dementiap. 157
Psychiatric Complicationsp. 158
Depressionp. 159
Maniap. 159
Insomniap. 159
Dermatologic Complicationsp. 159
Herpes Simplex Infectionp. 159
Varicella-Zoster Infectionp. 160
Molluscum Contagiosump. 160
Oral Hairy Leukoplakiap. 160
Wartsp. 160
Staphylococcal Infectionsp. 161
Bacillary Angiomatosisp. 161
Fungal Infectionsp. 162
Seborrheic Dermatitisp. 162
Psoriasisp. 162
Eosinophilic Folliculitisp. 163
Xerosis/Ichthyosisp. 163
HIV Infection and Pregnancyp. 164
Overviewp. 165
Initial Evaluationp. 165
Initiation of Antiretroviral Therapy in Pregnancyp. 166
Goals of Therapy and Monitoringp. 166
Management of HIV-Infected Pregnant Women Currently Receiving Antiretroviral Therapyp. 168
Other Management and Monitoring Considerationsp. 168
Postpartum Managementp. 169
Post-Exposure Prophylaxisp. 180
Occupational Post-Exposure Prophylaxisp. 181
Nonoccupational Post-Exposure Prophylaxisp. 187
Evaluationp. 187
Use of Antiretroviral Therapyp. 187
Follow-Up Testingp. 188
Antiretroviral Drug Summariesp. 190
p. 236
IAS-USA Drug Resistance Mutations in HIVp. 237
User Notesp. 243
References to the User Notesp. 247
p. 250
Selected Key Internet Resourcesp. 251
Referencep. 252
Indexp. 253
Table of Contents provided by Ingram. All Rights Reserved.


Please wait while the item is added to your cart...